BEAM
Price
$24.72
Change
+$1.69 (+7.34%)
Updated
Oct 11 closing price
22 days until earnings call
CRSP
Price
$46.85
Change
+$1.46 (+3.22%)
Updated
Oct 11 closing price
17 days until earnings call
Ad is loading...

BEAM vs CRSP

Header iconBEAM vs CRSP Comparison
Open Charts BEAM vs CRSPBanner chart's image
Beam Therapeutics
Price$24.72
Change+$1.69 (+7.34%)
Volume$882.87K
CapitalizationN/A
CRISPR Therapeutics AG
Price$46.85
Change+$1.46 (+3.22%)
Volume$1.11M
CapitalizationN/A
View a ticker or compare two or three
BEAM vs CRSP Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BEAM vs. CRSP commentary
Oct 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and CRSP is a Hold.

COMPARISON
Comparison
Oct 13, 2024
Stock price -- (BEAM: $24.72 vs. CRSP: $46.85)
Brand notoriety: BEAM and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 125% vs. CRSP: 108%
Market capitalization -- BEAM: $2.06B vs. CRSP: $4B
BEAM [@Biotechnology] is valued at $2.06B. CRSP’s [@Biotechnology] market capitalization is $4B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 4 bearish.
  • CRSP’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CRSP.

Price Growth

BEAM (@Biotechnology) experienced а +5.60% price change this week, while CRSP (@Biotechnology) price change was +3.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

CRSP is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4B) has a higher market cap than BEAM($2.07B). BEAM YTD gains are higher at: -9.184 vs. CRSP (-25.160). BEAM has higher annual earnings (EBITDA): -162.88M vs. CRSP (-335.17M). BEAM has more cash in the bank: 1.01B vs. CRSP (484M). BEAM has less debt than CRSP: BEAM (165M) vs CRSP (231M). BEAM has higher revenues than CRSP: BEAM (353M) vs CRSP (200M).
BEAMCRSPBEAM / CRSP
Capitalization2.07B4B52%
EBITDA-162.88M-335.17M49%
Gain YTD-9.184-25.16037%
P/E RatioN/AN/A-
Revenue353M200M177%
Total Cash1.01B484M208%
Total Debt165M231M71%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCRSP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend about 1 month ago
81%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 12 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X63193.023000747.933600
+1.20%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+3.22%
BEAM - CRSP
73%
Closely correlated
+7.34%
NTLA - CRSP
71%
Closely correlated
+4.44%
EDIT - CRSP
68%
Closely correlated
+7.77%
PRME - CRSP
57%
Loosely correlated
+1.68%
RXRX - CRSP
57%
Loosely correlated
+7.12%
More